ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China ...

‘Fake it till you make it’ is meant to encourage people to imagine themselves in a place of success. To imagine that with hard work and dedication you can experience success and the good things that ...